Nature Search

Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines

C Ferlini
G Scambia
S Mancuso
ResearchOpen Access18 Dec 1998
British Journal of Cancer

Volume: 79, P: 257-263
Synergistic antiproliferative activity of tamoxifen and docetaxel on three oestrogen receptor-negative cancer cell lines is mediated by the induction of apoptosis

C Ferlini
G Scambia
S Mancuso
Research01 Mar 1997
British Journal of Cancer

Volume: 75, P: 884-891
Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitors

C Ferlini
M Distefano
G Scambia
ResearchOpen Access05 Dec 2000
British Journal of Cancer

Volume: 83, P: 1762-1768
Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin

S Wang
X Huang
B Liu
Research24 May 2010
Oncogene

Volume: 29, P: 4225-4236
Severe congenital muscular dystrophy in a Mexican family with a new nonsense mutation (R2578X) in the laminin α-2 gene

R. M. Coral-Vazquez
H. Rosas-Vargas
F. Salamanca
Research01 Feb 2003
Journal of Human Genetics

Volume: 48, P: 91-95
Mutations in CEP290, which encodes a centrosomal protein, cause pleiotropic forms of Joubert syndrome

Enza Maria Valente
Jennifer L Silhavy
Joseph G Gleeson
Research07 May 2006
Nature Genetics

Volume: 38, P: 623-625
Ocular changes in familial amyloidotic polyneuropathy with dense vitreous opacities

J Guilherme Monteiro
A F F Martins
P Pinho Costa
Research01 Jan 1991
Eye

Volume: 5, P: 99-105
A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate

M J Scandlyn
E C Stuart
R J Rosengren
ResearchOpen Access16 Sept 2008
British Journal of Cancer

Volume: 99, P: 1056-1063
Production of a signal by irradiated cells which leads to a response in unirradiated cells characteristic of initiation of apoptosis

F M Lyng
C B Seymour
C Mothersill
ResearchOpen Access10 Oct 2000
British Journal of Cancer

Volume: 83, P: 1223-1230
Recommendations for whole genome sequencing in diagnostics for rare diseases

Erika Souche
Sergi Beltran
Marjan M. Weiss
ResearchOpen Access16 May 2022
European Journal of Human Genetics

Volume: 30, P: 1017-1021
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

A cross-ancestry genome-wide association meta-analysis of amyotrophic lateral sclerosis (ALS) including 29,612 patients with ALS and 122,656 controls identifies 15 risk loci with distinct genetic architectures and neuron-specific biology.

Wouter van Rheenen
Rick A. A. van der Spek
Jan H. Veldink
ResearchOpen Access06 Dec 2021
Nature Genetics

Volume: 53, P: 1636-1648
Screening of mutations in the CFTR gene in 1195 couples entering assisted reproduction technique programs

Liborio Stuppia
Ivana Antonucci
Bruno Dallapiccola
Research04 May 2005
European Journal of Human Genetics

Volume: 13, P: 959-964
Antitumour and antiangiogenic effects of IDN 5390, a novel C-seco taxane, in a paclitaxel-resistant human ovarian tumour xenograft

G Petrangolini
G Cassinelli
F Zunino
ResearchOpen Access09 Mar 2004
British Journal of Cancer

Volume: 90, P: 1464-1468
Correction to: Solving patients with rare diseases through programmatic reanalysis of genome-phenome data

Leslie Matalonga
Carles Hernández-Ferrer
Andreas Rump
Amendments and Corrections16 Aug 2021
European Journal of Human Genetics

Volume: 29, P: 1466-1469
Solving patients with rare diseases through programmatic reanalysis of genome-phenome data

Leslie Matalonga
Carles Hernández-Ferrer
Andreas Rump
ResearchOpen Access01 Jun 2021
European Journal of Human Genetics

Volume: 29, P: 1337-1347
Class III β-tubulin expression and in vitro resistance to microtubule targeting agents

C Stengel
S P Newman
A Purohit
ResearchOpen Access22 Dec 2009
British Journal of Cancer

Volume: 102, P: 316-324
Phenotypic spectrum and prevalence of INPP5E mutations in Joubert Syndrome and related disorders

Lorena Travaglini
Francesco Brancati
Enza Maria Valente
Research06 Feb 2013
European Journal of Human Genetics

Volume: 21, P: 1074-1078
Influence of silybin on biophysical properties of phospholipid bilayers

Olga Wesołowska
Barbara łania-pietrzak
Krystyna Michalak
Research01 Feb 2007
Acta Pharmacologica Sinica

Volume: 28, P: 296-306
Exome reanalysis and proteomic profiling identified TRIP4 as a novel cause of cerebellar hypoplasia and spinal muscular atrophy (PCH1)

Ana Töpf
Angela Pyle
Rita Horvath
ResearchOpen Access01 Jun 2021
European Journal of Human Genetics

Volume: 29, P: 1348-1353
Correction to: Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases

Birte Zurek
Kornelia Ellwanger
Andreas Rump
Amendments and Corrections13 Aug 2021
European Journal of Human Genetics

Volume: 29, P: 1459-1461
TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy

Pietro Spitali
Irina Zaharieva
Annemieke Aartsma-Rus
ResearchOpen Access02 Jan 2020
European Journal of Human Genetics

Volume: 28, P: 815-825
Dystrophin restoration in skeletal, heart and skin arrector pili smooth muscle of mdx mice by ZM2 NP–AON complexes

A Ferlini
P Sabatelli
P Rimessi
Research12 Nov 2009
Gene Therapy

Volume: 17, P: 432-438
Correction: Solving unsolved rare neurological diseases—a Solve-RD viewpoint

Rebecca Schüle
Dagmar Timmann
Andreas Rump
Amendments and Corrections25 Aug 2021
European Journal of Human Genetics

Volume: 29, P: 1462-1465
Comprehensive reanalysis for CNVs in ES data from unsolved rare disease cases results in new diagnoses

German Demidov
Burcu Yaldiz
Steven Laurie
ResearchOpen Access26 Oct 2024
npj Genomic Medicine

Volume: 9, P: 1-24
Sepsis modulates cortical excitability and alters the local and systemic hemodynamic response to seizures

Lorenzo Ferlini
Antoine Nonclercq
Nicolas Gaspard
ResearchOpen Access05 Jul 2022
Scientific Reports

Volume: 12, P: 1-10
Therapeutic approaches for Duchenne muscular dystrophy

Duchenne muscular dystrophy is an inherited muscle-wasting disease caused by mutations that disrupt production of dystrophin protein. This Review discusses the plethora of therapeutic approaches being developed to restore dystrophin function, such as exon skipping, gene replacement, cell therapy and gene editing, and highlights recent clinical approvals.

Thomas C. Roberts
Matthew J. A. Wood
Kay E. Davies
Reviews31 Aug 2023
Nature Reviews Drug Discovery

Volume: 22, P: 917-934
Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

Wouter van Rheenen
Rick A. A. van der Spek
Jan H. Veldink
Amendments and CorrectionsOpen Access31 Jan 2022
Nature Genetics

Volume: 54, P: 361
Solving unsolved rare neurological diseases—a Solve-RD viewpoint

Rebecca Schüle
Dagmar Timmann
Andreas Rump
ReviewsOpen Access10 May 2021
European Journal of Human Genetics

Volume: 29, P: 1332-1336
Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases

Birte Zurek
Kornelia Ellwanger
Andreas Rump
ReviewsOpen Access01 Jun 2021
European Journal of Human Genetics

Volume: 29, P: 1325-1331

Search

Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines

Synergistic antiproliferative activity of tamoxifen and docetaxel on three oestrogen receptor-negative cancer cell lines is mediated by the induction of apoptosis

Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitors

Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin

Severe congenital muscular dystrophy in a Mexican family with a new nonsense mutation (R2578X) in the laminin α-2 gene

Mutations in CEP290, which encodes a centrosomal protein, cause pleiotropic forms of Joubert syndrome

Ocular changes in familial amyloidotic polyneuropathy with dense vitreous opacities

A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate

Production of a signal by irradiated cells which leads to a response in unirradiated cells characteristic of initiation of apoptosis

Recommendations for whole genome sequencing in diagnostics for rare diseases

Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

Screening of mutations in the CFTR gene in 1195 couples entering assisted reproduction technique programs

Antitumour and antiangiogenic effects of IDN 5390, a novel C-seco taxane, in a paclitaxel-resistant human ovarian tumour xenograft

Correction to: Solving patients with rare diseases through programmatic reanalysis of genome-phenome data

Solving patients with rare diseases through programmatic reanalysis of genome-phenome data

Class III β-tubulin expression and in vitro resistance to microtubule targeting agents

Phenotypic spectrum and prevalence of INPP5E mutations in Joubert Syndrome and related disorders

Influence of silybin on biophysical properties of phospholipid bilayers

Exome reanalysis and proteomic profiling identified TRIP4 as a novel cause of cerebellar hypoplasia and spinal muscular atrophy (PCH1)

Correction to: Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases

TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy

Dystrophin restoration in skeletal, heart and skin arrector pili smooth muscle of mdx mice by ZM2 NP–AON complexes

Correction: Solving unsolved rare neurological diseases—a Solve-RD viewpoint

Comprehensive reanalysis for CNVs in ES data from unsolved rare disease cases results in new diagnoses

Sepsis modulates cortical excitability and alters the local and systemic hemodynamic response to seizures

Therapeutic approaches for Duchenne muscular dystrophy

Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

Solving unsolved rare neurological diseases—a Solve-RD viewpoint

Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases

Search

Quick links

Search

Filter By:

Search

Quick links